Sexual Wellness Market by Product Type (Condoms, Fertility & Pregnancy Rapid Test Kits, Intimate Care), Distribution Channel (Online Retailers, Pharmacies & Drug Stores, Specialty Stores), Age Group, End-user - Global Forecast 2025-2032
Description
The Sexual Wellness Market was valued at USD 897.76 million in 2024 and is projected to grow to USD 958.65 million in 2025, with a CAGR of 7.69%, reaching USD 1,624.65 million by 2032.
Framing the contemporary sexual wellness landscape as a convergence of preventative health, pleasure technology, and digitally enabled consumer experiences
The sexual wellness category has evolved from a narrowly defined set of commodities into an interconnected ecosystem spanning preventive products, intimate care, pleasure technologies, and wellness-focused supplements. Consumer attitudes have shifted markedly toward proactive sexual health and wellbeing, with emphasis on safety, inclusivity, and science-backed formulations. Meanwhile, digital-native channels and discreet, education-forward branding have accelerated adoption across age cohorts, reshaping competitive dynamics and raising expectations for product transparency and efficacy.
Against this backdrop, manufacturers, retailers, payers, and policymakers now face a more complex operating environment that requires integrated strategies across product development, regulatory compliance, distribution design, and marketing. This introduction synthesizes the contemporary drivers shaping demand and outlines the critical axes on which competition and differentiation are being forged, providing a practical foundation for decision-makers seeking to align investment and innovation with evolving consumer and institutional priorities.
Understanding how consumer health prioritization, material innovation, regulatory clarity, and omnichannel distribution are reshaping competitive advantage in sexual wellness
The market's landscape is undergoing transformative shifts driven by four interdependent forces: consumer health prioritization, technological innovation, regulatory evolution, and distribution channel metamorphosis. Consumers are reframing sexual wellness as an integral part of overall health, prompting demand for clinically validated products and transparent ingredient and safety information. In parallel, advances in materials science, miniaturized electronics, and app-enabled product ecosystems are accelerating the development of new devices and formulation platforms, increasing product sophistication and creating new value pools.
Regulatory frameworks are responding incrementally, moving toward clearer standards for device classification, ingredient disclosure, and cross-border trade compliance. Consequently, brands are investing in evidence generation and quality assurance to reduce market entry friction and build trust. Distribution is also shifting: direct-to-consumer and subscription models complement traditional retail footprints, and omnichannel strategies are becoming table stakes for brands that wish to optimize acquisition and retention across demographics. Together, these shifts are changing how products are conceived, validated, and delivered to end users, and they are forcing incumbents and new entrants alike to adopt more integrated, insight-driven approaches.
Assessing how 2025 United States tariff adjustments are altering sourcing decisions, pricing strategies, and resilience planning across product and device supply chains
The 2025 tariffs enacted by the United States have introduced a range of operational and commercial pressures across product categories that are sensitive to trade costs and cross-border supply chains. For manufacturers sourcing components such as elastomers, silicone formulations, small motors, batteries, or electronic control modules, incremental duties increase landed cost and compress margins unless firms can realize productivity gains or adjust pricing strategies. Importantly, tariff impacts are not uniform: low-margin commoditized goods feel immediate pricing pressure, while differentiated, technology-enabled devices have greater latitude to absorb cost increases or invest in compliance and certification that justify premium positioning.
In response, several tactical responses have emerged. Supply diversification and nearshoring have accelerated as firms prioritize resilience and lead-time reduction over absolute cost arbitrage. Meanwhile, procurement teams are seeking alternative material specifications and supplier partnerships that reduce exposure to tariffed inputs without sacrificing safety or performance. At the commercialization level, brands are re-evaluating packaging, labeling, and tariff classification strategies to ensure accurate duty treatment and to mitigate unintended tariff triggers tied to mixed-function products. Finally, trade policy uncertainty has heightened the value of scenario planning: firms that integrate tariff contingencies into product road maps and channel pricing models are better positioned to protect both margin and market access as policy evolves.
Dissecting demand and go-to-market implications through an integrated lens of product type, channel behaviors, age cohorts, and end-user physiological and purchase roles
Segmentation insights reveal distinct demand drivers and operational implications across product type, distribution channel, age cohort, and end-user demographics. By product type, the category encompasses condoms, fertility and pregnancy rapid test kits, intimate care, personal lubricants, sexual enhancement supplements, and sexual wellness devices and toys, each carrying different regulatory, quality, and consumer-education requirements. Within personal lubricants, oil-based, silicone-based, and water-based variants present divergent formulation, sensory and compatibility trade-offs that determine pairing recommendations, shelf stability, and market positioning. Sexual enhancement supplements fragment into herbal supplements, hormonal boosters, and vitamins and minerals, which vary in clinical evidence expectations, labeling scrutiny, and cross-border regulatory complexity.
Channel segmentation similarly shapes commercial strategy: online retailers provide breadth, personalization, and data-driven cross-sell opportunities, pharmacies and drug stores deliver clinical legitimacy and point-of-care convenience, specialty stores offer experiential retail and product education, while supermarkets and hypermarkets provide mass visibility and impulse purchase dynamics. Age group segmentation shows clear behavior differentials across 18-24 years, 25-34 years, 35-44 years, and 45 & above cohorts, where younger consumers often prioritize discreet digital purchasing and trend-forward designs, mid-life cohorts seek performance and health-linked benefits, and older consumers emphasize safety, efficacy, and convenience. End-user segmentation by female and male highlights the need for targeted formulation, communication, and channel choices that reflect physiological differences, purchasing role, and cultural attitudes toward sexual health. Integrating these segmentation lenses enables more precise product development, messaging, and distribution alignments that reduce acquisition friction and increase lifetime value.
Evaluating how regional regulatory nuances, consumer cultural norms, and retail infrastructures are driving differentiated strategies across the Americas, EMEA, and Asia-Pacific
Regional dynamics reshape competitive priorities and investment focus across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each exhibiting distinct regulatory environments, consumer attitudes, and distribution architectures. In the Americas, strong digital adoption and a growing focus on preventive health accelerate uptake of lab-validated tests, app-enabled devices, and personalized subscription services, while trade policy shifts influence sourcing strategies and cost structures. Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts in some markets coexist with fragmented import rules and cultural nuance-driven demand patterns that favor localized product formulations and tailored communication approaches.
Asia-Pacific stands out for manufacturing scale, rapid e-commerce growth, and a rising middle-class consumer base open to innovation, which together create both sourcing advantages and heightened competition from local brands. Across regions, the interplay of public health policy, cultural norms, and retail infrastructure necessitates differentiated launch plans, regulatory road maps, and partnership models. Firms that align product attributes, evidence generation, and channel partnerships to regional specificities gain faster adoption and more sustainable advantage.
Summarizing how product validation, omnichannel orchestration, and supply chain resilience are shaping the competitive frontier among leading industry players
Competitive dynamics center on three interrelated dimensions: product innovation and evidence, channel orchestration, and operational resilience. Leading firms are investing in clinical validation, high-quality materials, and user experience design to convert safety and efficacy into a durable point of differentiation. At the same time, successful companies are orchestrating multi-channel distribution playbooks that balance the scale and precision of online retailers with the trust and accessibility of pharmacies and the experiential benefit of specialty retail.
Operationally, companies that proactively address supply chain risk, tariff exposure, and quality control across complex supplier networks realize measurable advantages in time-to-market and margin preservation. Strategic partnerships, licensing deals, and selective acquisitions are being used to accelerate entry into adjacent categories and to secure proprietary technologies. Finally, brands that prioritize clear, stigma-reducing education and that build privacy-forward purchase experiences win stronger engagement across diverse age and gender segments, converting one-time buyers into repeat purchasers through trust and relevance.
Delivering five prioritized strategic moves that align evidence-based product innovation, tariff-aware sourcing, and channel-tailored customer journeys to accelerate growth and resilience
Actionable recommendations for industry leaders focus on five prioritized moves that align short-term resilience with long-term differentiation. First, embed evidence-generation into new product development cycles to convert quality into commercial credibility and to reduce regulatory friction across jurisdictions. Second, redesign procurement and sourcing strategies to blend cost competitiveness with tariff-aware supplier diversification, including nearshoring where it materially improves lead times and risk exposure. Third, adopt channel-specific merchandising and customer journeys that align product format and messaging with the dominant behaviors of online retailers, pharmacies, specialty stores, and supermarkets, thereby improving conversion and retention. Fourth, invest in privacy-first digital experiences and educational content that destigmatize purchasing and support repeat buying, particularly among younger cohorts that rely on discreet, app-enabled interactions. Fifth, pursue selective partnerships and technology licensing to accelerate capability build without overextending R&D timelines or capital commitments.
Collectively, these moves should be executed through a cross-functional program management approach that links R&D, regulatory, procurement, commercial, and customer insights teams. By establishing clear metrics for evidence milestones, supplier risk, channel economics, and customer lifetime value, leaders can translate these strategic moves into measurable outcomes and tighter alignment between investment and market response.
Explaining a mixed-methods research approach that combines in-depth stakeholder interviews, regulatory review, and triangulated segmentation analysis for actionable insights
The research methodology employed a mixed-methods approach that integrates primary qualitative interviews, secondary literature synthesis, and structured data triangulation to ensure robust insight generation. Primary research included in-depth interviews with manufacturers, channel partners, regulatory advisors, and clinicians to surface operational realities and evolving demand signals. Secondary research drew on publicly available regulatory guidance, patent filings, and trade publications to map technological trajectories and policy changes. Throughout, data points were cross-validated across multiple sources to reduce bias and to surface convergent themes.
Segmentation frameworks were developed by mapping product characteristics, distribution behaviors, demographic trends, and end-user needs, and these were stress-tested through scenario analyses to evaluate sensitivity to tariff changes and channel shifts. Limitations were acknowledged and addressed through conservative interpretation of anecdotal inputs and by highlighting areas where further primary data collection would materially enhance granularity. The result is a methodology that emphasizes triangulation, transparency, and pragmatic applicability for commercial decision-making.
Concluding with a clear imperative to align evidence generation, supply chain strategy, and channel-specific go-to-market plans to secure durable competitive advantage
In conclusion, the sexual wellness sector is transitioning from fragmented categories toward an integrated health-and-wellness domain where product credibility, channel intelligence, and operational resilience determine sustained success. Consumer expectations for safety, efficacy, and discretion are becoming baseline requirements, prompting investment in evidence and user-centered design. Simultaneously, tariff developments and regional regulatory complexity are reshaping sourcing and pricing strategies, underscoring the need for proactive supply chain planning and scenario-based commercial models.
Organizations that marshal cross-functional alignment, invest in targeted evidence generation, and tailor their go-to-market strategies to product, channel, demographic, and regional specificities will be best positioned to capture durable value. The path forward requires deliberate coordination of R&D, procurement, regulatory strategy, and marketing execution to convert market insight into competitive advantage.
Please Note: PDF & Excel + Online Access - 1 Year
Framing the contemporary sexual wellness landscape as a convergence of preventative health, pleasure technology, and digitally enabled consumer experiences
The sexual wellness category has evolved from a narrowly defined set of commodities into an interconnected ecosystem spanning preventive products, intimate care, pleasure technologies, and wellness-focused supplements. Consumer attitudes have shifted markedly toward proactive sexual health and wellbeing, with emphasis on safety, inclusivity, and science-backed formulations. Meanwhile, digital-native channels and discreet, education-forward branding have accelerated adoption across age cohorts, reshaping competitive dynamics and raising expectations for product transparency and efficacy.
Against this backdrop, manufacturers, retailers, payers, and policymakers now face a more complex operating environment that requires integrated strategies across product development, regulatory compliance, distribution design, and marketing. This introduction synthesizes the contemporary drivers shaping demand and outlines the critical axes on which competition and differentiation are being forged, providing a practical foundation for decision-makers seeking to align investment and innovation with evolving consumer and institutional priorities.
Understanding how consumer health prioritization, material innovation, regulatory clarity, and omnichannel distribution are reshaping competitive advantage in sexual wellness
The market's landscape is undergoing transformative shifts driven by four interdependent forces: consumer health prioritization, technological innovation, regulatory evolution, and distribution channel metamorphosis. Consumers are reframing sexual wellness as an integral part of overall health, prompting demand for clinically validated products and transparent ingredient and safety information. In parallel, advances in materials science, miniaturized electronics, and app-enabled product ecosystems are accelerating the development of new devices and formulation platforms, increasing product sophistication and creating new value pools.
Regulatory frameworks are responding incrementally, moving toward clearer standards for device classification, ingredient disclosure, and cross-border trade compliance. Consequently, brands are investing in evidence generation and quality assurance to reduce market entry friction and build trust. Distribution is also shifting: direct-to-consumer and subscription models complement traditional retail footprints, and omnichannel strategies are becoming table stakes for brands that wish to optimize acquisition and retention across demographics. Together, these shifts are changing how products are conceived, validated, and delivered to end users, and they are forcing incumbents and new entrants alike to adopt more integrated, insight-driven approaches.
Assessing how 2025 United States tariff adjustments are altering sourcing decisions, pricing strategies, and resilience planning across product and device supply chains
The 2025 tariffs enacted by the United States have introduced a range of operational and commercial pressures across product categories that are sensitive to trade costs and cross-border supply chains. For manufacturers sourcing components such as elastomers, silicone formulations, small motors, batteries, or electronic control modules, incremental duties increase landed cost and compress margins unless firms can realize productivity gains or adjust pricing strategies. Importantly, tariff impacts are not uniform: low-margin commoditized goods feel immediate pricing pressure, while differentiated, technology-enabled devices have greater latitude to absorb cost increases or invest in compliance and certification that justify premium positioning.
In response, several tactical responses have emerged. Supply diversification and nearshoring have accelerated as firms prioritize resilience and lead-time reduction over absolute cost arbitrage. Meanwhile, procurement teams are seeking alternative material specifications and supplier partnerships that reduce exposure to tariffed inputs without sacrificing safety or performance. At the commercialization level, brands are re-evaluating packaging, labeling, and tariff classification strategies to ensure accurate duty treatment and to mitigate unintended tariff triggers tied to mixed-function products. Finally, trade policy uncertainty has heightened the value of scenario planning: firms that integrate tariff contingencies into product road maps and channel pricing models are better positioned to protect both margin and market access as policy evolves.
Dissecting demand and go-to-market implications through an integrated lens of product type, channel behaviors, age cohorts, and end-user physiological and purchase roles
Segmentation insights reveal distinct demand drivers and operational implications across product type, distribution channel, age cohort, and end-user demographics. By product type, the category encompasses condoms, fertility and pregnancy rapid test kits, intimate care, personal lubricants, sexual enhancement supplements, and sexual wellness devices and toys, each carrying different regulatory, quality, and consumer-education requirements. Within personal lubricants, oil-based, silicone-based, and water-based variants present divergent formulation, sensory and compatibility trade-offs that determine pairing recommendations, shelf stability, and market positioning. Sexual enhancement supplements fragment into herbal supplements, hormonal boosters, and vitamins and minerals, which vary in clinical evidence expectations, labeling scrutiny, and cross-border regulatory complexity.
Channel segmentation similarly shapes commercial strategy: online retailers provide breadth, personalization, and data-driven cross-sell opportunities, pharmacies and drug stores deliver clinical legitimacy and point-of-care convenience, specialty stores offer experiential retail and product education, while supermarkets and hypermarkets provide mass visibility and impulse purchase dynamics. Age group segmentation shows clear behavior differentials across 18-24 years, 25-34 years, 35-44 years, and 45 & above cohorts, where younger consumers often prioritize discreet digital purchasing and trend-forward designs, mid-life cohorts seek performance and health-linked benefits, and older consumers emphasize safety, efficacy, and convenience. End-user segmentation by female and male highlights the need for targeted formulation, communication, and channel choices that reflect physiological differences, purchasing role, and cultural attitudes toward sexual health. Integrating these segmentation lenses enables more precise product development, messaging, and distribution alignments that reduce acquisition friction and increase lifetime value.
Evaluating how regional regulatory nuances, consumer cultural norms, and retail infrastructures are driving differentiated strategies across the Americas, EMEA, and Asia-Pacific
Regional dynamics reshape competitive priorities and investment focus across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each exhibiting distinct regulatory environments, consumer attitudes, and distribution architectures. In the Americas, strong digital adoption and a growing focus on preventive health accelerate uptake of lab-validated tests, app-enabled devices, and personalized subscription services, while trade policy shifts influence sourcing strategies and cost structures. Europe, Middle East & Africa presents a heterogeneous landscape where regulatory harmonization efforts in some markets coexist with fragmented import rules and cultural nuance-driven demand patterns that favor localized product formulations and tailored communication approaches.
Asia-Pacific stands out for manufacturing scale, rapid e-commerce growth, and a rising middle-class consumer base open to innovation, which together create both sourcing advantages and heightened competition from local brands. Across regions, the interplay of public health policy, cultural norms, and retail infrastructure necessitates differentiated launch plans, regulatory road maps, and partnership models. Firms that align product attributes, evidence generation, and channel partnerships to regional specificities gain faster adoption and more sustainable advantage.
Summarizing how product validation, omnichannel orchestration, and supply chain resilience are shaping the competitive frontier among leading industry players
Competitive dynamics center on three interrelated dimensions: product innovation and evidence, channel orchestration, and operational resilience. Leading firms are investing in clinical validation, high-quality materials, and user experience design to convert safety and efficacy into a durable point of differentiation. At the same time, successful companies are orchestrating multi-channel distribution playbooks that balance the scale and precision of online retailers with the trust and accessibility of pharmacies and the experiential benefit of specialty retail.
Operationally, companies that proactively address supply chain risk, tariff exposure, and quality control across complex supplier networks realize measurable advantages in time-to-market and margin preservation. Strategic partnerships, licensing deals, and selective acquisitions are being used to accelerate entry into adjacent categories and to secure proprietary technologies. Finally, brands that prioritize clear, stigma-reducing education and that build privacy-forward purchase experiences win stronger engagement across diverse age and gender segments, converting one-time buyers into repeat purchasers through trust and relevance.
Delivering five prioritized strategic moves that align evidence-based product innovation, tariff-aware sourcing, and channel-tailored customer journeys to accelerate growth and resilience
Actionable recommendations for industry leaders focus on five prioritized moves that align short-term resilience with long-term differentiation. First, embed evidence-generation into new product development cycles to convert quality into commercial credibility and to reduce regulatory friction across jurisdictions. Second, redesign procurement and sourcing strategies to blend cost competitiveness with tariff-aware supplier diversification, including nearshoring where it materially improves lead times and risk exposure. Third, adopt channel-specific merchandising and customer journeys that align product format and messaging with the dominant behaviors of online retailers, pharmacies, specialty stores, and supermarkets, thereby improving conversion and retention. Fourth, invest in privacy-first digital experiences and educational content that destigmatize purchasing and support repeat buying, particularly among younger cohorts that rely on discreet, app-enabled interactions. Fifth, pursue selective partnerships and technology licensing to accelerate capability build without overextending R&D timelines or capital commitments.
Collectively, these moves should be executed through a cross-functional program management approach that links R&D, regulatory, procurement, commercial, and customer insights teams. By establishing clear metrics for evidence milestones, supplier risk, channel economics, and customer lifetime value, leaders can translate these strategic moves into measurable outcomes and tighter alignment between investment and market response.
Explaining a mixed-methods research approach that combines in-depth stakeholder interviews, regulatory review, and triangulated segmentation analysis for actionable insights
The research methodology employed a mixed-methods approach that integrates primary qualitative interviews, secondary literature synthesis, and structured data triangulation to ensure robust insight generation. Primary research included in-depth interviews with manufacturers, channel partners, regulatory advisors, and clinicians to surface operational realities and evolving demand signals. Secondary research drew on publicly available regulatory guidance, patent filings, and trade publications to map technological trajectories and policy changes. Throughout, data points were cross-validated across multiple sources to reduce bias and to surface convergent themes.
Segmentation frameworks were developed by mapping product characteristics, distribution behaviors, demographic trends, and end-user needs, and these were stress-tested through scenario analyses to evaluate sensitivity to tariff changes and channel shifts. Limitations were acknowledged and addressed through conservative interpretation of anecdotal inputs and by highlighting areas where further primary data collection would materially enhance granularity. The result is a methodology that emphasizes triangulation, transparency, and pragmatic applicability for commercial decision-making.
Concluding with a clear imperative to align evidence generation, supply chain strategy, and channel-specific go-to-market plans to secure durable competitive advantage
In conclusion, the sexual wellness sector is transitioning from fragmented categories toward an integrated health-and-wellness domain where product credibility, channel intelligence, and operational resilience determine sustained success. Consumer expectations for safety, efficacy, and discretion are becoming baseline requirements, prompting investment in evidence and user-centered design. Simultaneously, tariff developments and regional regulatory complexity are reshaping sourcing and pricing strategies, underscoring the need for proactive supply chain planning and scenario-based commercial models.
Organizations that marshal cross-functional alignment, invest in targeted evidence generation, and tailor their go-to-market strategies to product, channel, demographic, and regional specificities will be best positioned to capture durable value. The path forward requires deliberate coordination of R&D, procurement, regulatory strategy, and marketing execution to convert market insight into competitive advantage.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
189 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Growing demand for plant-based and sustainable sexual wellness products reducing environmental impact
- 5.2. Integration of AI-driven personalized sexual health coaching apps for tailored intimacy improvement
- 5.3. Surge in direct-to-consumer intimate hygiene brands emphasizing hypoallergenic and fragrance-free formulations
- 5.4. Expansion of telemedicine platforms offering discreet virtual consultations and prescription services for sexual dysfunction
- 5.5. Increasing popularity of inclusive and size-adaptive lingerie lines promoting body positivity and diversity representation
- 5.6. Collaboration between sexual wellness brands and mental health experts to address intimacy anxiety and relationship communication
- 5.7. Development of microbiome-friendly lubricants backed by clinical research to support vaginal flora health
- 5.8. Rising consumer interest in ethical brand transparency with full supply chain and ingredient traceability
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Sexual Wellness Market, by Product Type
- 8.1. Condoms
- 8.2. Fertility & Pregnancy Rapid Test Kits
- 8.3. Intimate Care
- 8.4. Personal Lubricants
- 8.4.1. Oil-Based
- 8.4.2. Silicone-Based
- 8.4.3. Water-Based
- 8.5. Sexual Enhancement Supplements
- 8.5.1. Herbal Supplements
- 8.5.2. Hormonal Boosters
- 8.5.3. Vitamins & Minerals
- 8.6. Sexual Wellness Devices & Toys
- 9. Sexual Wellness Market, by Distribution Channel
- 9.1. Online Retailers
- 9.2. Pharmacies & Drug Stores
- 9.3. Specialty Stores
- 9.4. Supermarkets & Hypermarkets
- 10. Sexual Wellness Market, by Age Group
- 10.1. 18-24 Years
- 10.2. 25-34 Years
- 10.3. 35-44 Years
- 10.4. 45 & Above
- 11. Sexual Wellness Market, by End-user
- 11.1. Female
- 11.2. Male
- 12. Sexual Wellness Market, by Region
- 12.1. Americas
- 12.1.1. North America
- 12.1.2. Latin America
- 12.2. Europe, Middle East & Africa
- 12.2.1. Europe
- 12.2.2. Middle East
- 12.2.3. Africa
- 12.3. Asia-Pacific
- 13. Sexual Wellness Market, by Group
- 13.1. ASEAN
- 13.2. GCC
- 13.3. European Union
- 13.4. BRICS
- 13.5. G7
- 13.6. NATO
- 14. Sexual Wellness Market, by Country
- 14.1. United States
- 14.2. Canada
- 14.3. Mexico
- 14.4. Brazil
- 14.5. United Kingdom
- 14.6. Germany
- 14.7. France
- 14.8. Russia
- 14.9. Italy
- 14.10. Spain
- 14.11. China
- 14.12. India
- 14.13. Japan
- 14.14. Australia
- 14.15. South Korea
- 15. Competitive Landscape
- 15.1. Market Share Analysis, 2024
- 15.2. FPNV Positioning Matrix, 2024
- 15.3. Competitive Analysis
- 15.3.1. Aneros
- 15.3.2. Bijoux Indiscrets SL
- 15.3.3. BioFilm, Inc. by Combe Incorporated
- 15.3.4. BMS Factory
- 15.3.5. California Exotic Novelties, LLC
- 15.3.6. Church & Dwight Co.,Inc.
- 15.3.7. Convex Latex Pvt. Ltd.
- 15.3.8. Dabur Ltd.
- 15.3.9. Diamond Products
- 15.3.10. Doc Johnson Enterprises
- 15.3.11. HANX
- 15.3.12. HLL Lifecare Ltd.
- 15.3.13. Hot Octopuss Ltd.
- 15.3.14. Karex Berhad
- 15.3.15. Kessel Medintim GmbH
- 15.3.16. Kindly Health
- 15.3.17. LELOi AB
- 15.3.18. LifeStyles Healthcare Pte. Ltd.
- 15.3.19. Lovehoney Group
- 15.3.20. Lovelife by OhMiBod
- 15.3.21. Mankind Pharma Ltd.
- 15.3.22. Okamoto Industries,Inc.
- 15.3.23. Reckitt Benckiser Group PLC
- 15.3.24. Sagami Rubber Industries Co., Ltd.
- 15.3.25. Satisfyer
- 15.3.26. Tantus, Inc
- 15.3.27. TENGA Co., Ltd.
- 15.3.28. Topco Sales
- 15.3.29. Vella Bioscience, Inc.
- 15.3.30. Veru Inc.
- 15.3.31. WOW Tech Group
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
